Somnee builds an AI-powered neurotech headband that uses proprietary EEG+ and AI technology to map brain activity and deliver personalized, non-invasive stimulation to guide users into deeper, faster sleep. Clinical study results reported faster sleep onset (twice as fast), over 30 minutes longer sleep, and a one-third reduction in tossing and turning; the company says it outperforms melatonin, CBT‑i, and Ambien in those measures. Its therapeutic approach is backed by clinical studies and covered by 24 patents. Somnee is preparing to launch a second-generation headband and a SmartSleep AI operating system that enables personalized brain mapping, real-time monitoring, and AI-powered interventions throughout the sleep cycle. The second-generation product is in beta pilots with select NBA teams and performance staff, and the company has partnerships with Equinox Hotels and NBA programs. Somnee has relocated manufacturing out of China and expanded teams in Berkeley and India as it scales to address the sleep-aid market.

Total raised

$10M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2025